ARHGDIA Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-ARHGDIA antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityARHGDIA
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size0.1 mg
Concentration1mg/ml
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: Western blot analysis of extracts of various cell lines, using ARHGDIA antibody. Immunofluorescence analysis of HeLa cell using ARHGDIA antibody. Blue: DAPI for nuclear staining. Rho family small GTPases, including Rho, Rac and cdc42, act as molecular switches, regulating processes such as cell migration, adhesion, proliferation and differentiation. They are activated by guanine nucleotide exchange factors (GEFs), which catalyze the exchange of bound GDP for GTP, and inhibited by GTPase activating proteins (GAPs), which catalyze the hydrolysis of GTP to GDP. A third level of regulation is provided by the stoichiometric binding of Rho GDP dissociation inhibitor (RhoGDI). RhoGDI affects Rho activity by inhibiting nucleotide excha
ImmunogenImmunogen: Recombinant protein of human ARHGDIA
Other Names[ARHGDIA; Rho GDP-dissociation inhibitor 1; rho GDP-dissociation inhibitor 1; Rho GDP dissociation inhibitor alpha; Rho-GDI alpha], [ARHGDIA; ARHGDIA; GDIA1; NPHS8; RHOGDI; RHOGDI-1; HEL-S-47e; GDIA1; Rho GDI 1]
Gene, Accession #[ARHGDIA], Gene ID: 396, NCBI: CAG33058.1
Catalog #MBS419611
Price$385
Order / More InfoARHGDIA Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.